MARK BROWN: Open Payments
NPI 1578747515 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 38 payments from 13 companies in 2025. Trend: 2023 $955 · 2024 $849 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $136 |
| ABBVIE INC. | 5 | $104 |
| UCB, Inc. | 3 | $97 |
| PFIZER INC. | 4 | $97 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Almirall LLC | 1 | $16 |
Products named: TREMFYA, Bimzelx, CIBINQO, ILUMYA, SKYRIZI, Sotyktu, RINVOQ, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
